CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Healthy
Interventions
DRUG

1 (Lipitor®)

atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days

DRUG

1 (Ezetrol®)

After 11days withdrawal period, ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

1 (Lipitor®, Ezetrol®)

After 11days withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

2 (Ezetrol®)

ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

2(Lipitor®, Ezetrol®)

After 11days withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

2 (Lipitor®)

After 11day withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days

DRUG

3(Lipitor®, Ezetrol®)

atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

3 (Lipitor®)

After 11day withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days

DRUG

3 (Ezetrol®)

After 11day withdrawal period, ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

4 (Lipitor®)

atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days

DRUG

4(Lipitor®, Ezetrol®)

After 11days withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

4 (Ezetrol®)

After 11day withdrawal period, ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

5 (Ezetrol®)

ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

5 (Lipitor®)

After 11day withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days

DRUG

5 (Lipitor®, Ezetrol®)

After 11days withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

6(Lipitor®, Ezetrol®)

atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

6 (Ezetrol®)

After 11days withdrawal period, ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

DRUG

6 (Lipitor®)

After 11day withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days

Trial Locations (1)

Unknown

ChongKunDang, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT02288338 - CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers | Biotech Hunter | Biotech Hunter